drugset / Trial / NCT00509639

Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease

NCT00509639

Phase 3 Completed 74 enrolled S.L.A. Pharma AG
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare changes in Perianal Crohn's Disease following use of locally applied 10% metronidazole ointment and a placebo.

Timeline

Start
2005-05
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 0.7 g Topical